Tanfac Inds.
Tanfac Inds. Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
5 of 5 strong
The short version
FY27 revenue growth targeted at around 30% compared to FY26 (Page 9, Page 6). TANFAC targets 30% revenue growth in FY27 driven by new project launch (HFC-32) and ramp-up of existing capacities.
From Tanfac Inds.'s Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- FY27 revenue growth targeted at around 30% compared to FY26 (Page 9, Page 6).
- FY28 revenue expected to grow over 60% due to ramp-up of new projects and inorganic fluoride products (Page 6).
- R-32 volume guidance for FY28 is conservatively at 80%-85% utilization (Page 9).
- Solar grade DHF capacity planned to expand alongside solar wafer capacity growth from 35 GW to 210 GW by FY29 (Page 20).
- AHF capacity expansion of 20,000 to 30,000 tons planned with commissioning expected by FY28 (Page 15).
- Post R-32 project commissioning, revenue from R-32 alone expected to be INR 900-1,000 crores, with exports increasing to 50% of revenue (Page 9).
- Specialty fluorides and electronic grade fluorochemicals are also key growth areas being evaluated for future expansion (Pages 7, 15).
Profitability & Margins
See what Tanfac Inds. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Current ongoing capex: HFC-32 project with a total committed liability of INR 315 crores out of INR 395 crores; about INR 100 crores spent so far; commissioning expected by November-end 2026.
- Future capex plans (~INR 1,500 - 1,700 crores over next 4 years) include:
- - Expansion of Solar Grade DHF capacity (INR 30-40 crores), starting 6 months post HFC-32 commissioning.
- - Expansion of AHF (Anhydrous Hydrogen Fluoride) capacity (INR 120 crores), expected 12-15 months timeline.
- - Investment in value-added fluorochemicals and electronic-grade products, including inorganic fluorides and fluoropolymers (INR 150 crores).
- - Strategic focus on electronic grade HF for semiconductor applications, evaluating technology tie-ups to accelerate go-to-market.
- Planned phased investments until 2030-31 focusing on solar grade DHF, AHF, electronic grade, HFOs, and high-performing fluoropolymers.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Tanfac Inds. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- TANFAC Industries Limited has two firm contracts for R-32 and one Memorandum of Understanding (MoU) which is expected to convert into a contract soon.
- The MoU offtake is for 5,000 tons.
- Around 80% to 85% of the solar grade DHF plant capacity is contracted.
- Approximately 65% to 70% of the R-32 capacity is already booked under long-term contracts spanning 5 to 8 years.
- Long-term contracts include take-or-pay terms with pass-through pricing mechanisms.
- The company has placed about 65% of R-32 volume at a fixed EBITDA margin with remaining 30% sold on the spot market.
- Solar grade DHF capacity is currently fully sold out.
- TANFAC is evaluating technology tie-ups for electronic grade products and considering expansion capex accordingly.
Tanfac Inds. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹193 Cr, net profit ₹18 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Tanfac Industries Ltd's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Solar Industries India Ltd (Q1 FY27)
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
- Sudarshan Chemical Industries Ltd (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
- Indo Borax & Chemicals Ltd (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF Ltd (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
Frequently Asked Questions
What were Tanfac Inds. Q1 FY27 results?
FY27 revenue growth targeted at around 30% compared to FY26 (Page 9, Page 6). TANFAC targets 30% revenue growth in FY27 driven by new project launch (HFC-32) and ramp-up of existing capacities.
What is Tanfac Inds. share price analysis?
Tanfac Inds. currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 104.0 with a market cap of ₹7,038 Cr. Investors should review the full earnings analysis for detailed insights.
Is Tanfac Inds. planning capital expenditure?
Current ongoing capex: HFC-32 project with a total committed liability of INR 315 crores out of INR 395 crores; about INR 100 crores spent so far; commissioning expected by November-end 2026.
Keep Tanfac Inds. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.